ATE378415T1 - In cis regulierte konditionelle genvektoren - Google Patents

In cis regulierte konditionelle genvektoren

Info

Publication number
ATE378415T1
ATE378415T1 AT04021854T AT04021854T ATE378415T1 AT E378415 T1 ATE378415 T1 AT E378415T1 AT 04021854 T AT04021854 T AT 04021854T AT 04021854 T AT04021854 T AT 04021854T AT E378415 T1 ATE378415 T1 AT E378415T1
Authority
AT
Austria
Prior art keywords
cis
conditional gene
vector system
gene vectors
present
Prior art date
Application number
AT04021854T
Other languages
English (en)
Inventor
Wolfgang Hammerschmidt
Sibille Humme
Dagmar Pich
Aloys Schepers
Original Assignee
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsf Forschungszentrum Umwelt filed Critical Gsf Forschungszentrum Umwelt
Application granted granted Critical
Publication of ATE378415T1 publication Critical patent/ATE378415T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2820/00—Vectors comprising a special origin of replication system
    • C12N2820/002—Vectors comprising a special origin of replication system inducible or controllable
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2820/00—Vectors comprising a special origin of replication system
    • C12N2820/60—Vectors comprising a special origin of replication system from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C12N2830/003—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04021854T 2004-09-14 2004-09-14 In cis regulierte konditionelle genvektoren ATE378415T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04021854A EP1634955B1 (de) 2004-09-14 2004-09-14 In cis regulierte konditionelle Genvektoren

Publications (1)

Publication Number Publication Date
ATE378415T1 true ATE378415T1 (de) 2007-11-15

Family

ID=34926537

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04021854T ATE378415T1 (de) 2004-09-14 2004-09-14 In cis regulierte konditionelle genvektoren

Country Status (7)

Country Link
US (1) US7803617B2 (de)
EP (2) EP1634955B1 (de)
AT (1) ATE378415T1 (de)
DE (1) DE602004010112T2 (de)
DK (1) DK1634955T3 (de)
ES (1) ES2297315T3 (de)
WO (1) WO2006029831A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
ES2411962T3 (es) 2003-10-24 2013-07-09 Gencia Corporation Métodos y composiciones para suministrar polinucleótidos
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19635568C1 (de) * 1996-09-02 1998-03-26 Gsf Forschungszentrum Umwelt Vektorsysteme zur konditionalen Genexpression
IT1302403B1 (it) * 1998-11-06 2000-09-05 Angeletti P Ist Richerche Bio Cellule per la produzione di vettori adenovirali difettivi, metodoper la loro preparazione e loro uso.
US7723102B2 (en) * 2000-09-28 2010-05-25 Bayer Corporation Enhanced transfection system

Also Published As

Publication number Publication date
ES2297315T3 (es) 2008-05-01
EP1634955A1 (de) 2006-03-15
US7803617B2 (en) 2010-09-28
US20070184028A1 (en) 2007-08-09
EP1799834A1 (de) 2007-06-27
WO2006029831A1 (en) 2006-03-23
EP1634955B1 (de) 2007-11-14
DK1634955T3 (da) 2008-03-17
DE602004010112D1 (de) 2007-12-27
DE602004010112T2 (de) 2008-09-18

Similar Documents

Publication Publication Date Title
IL186772A0 (en) Glp-1 pegylated compounds
HK1205193A1 (en) Recombinant n-glycosylated proteins from procaryotic cells n-
MA32481B1 (fr) Compositions et procédés d'utilisation pour des anticorps thérapeutiques
WO2003048327A3 (en) Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
UA107921C2 (en) Variants of polypeptide of receptor ivr activin and their use
MX336807B (es) Composiciones y metodos para producir una composicion.
TW200611910A (en) Interferon-alpha polypeptides and conjugates
UA95446C2 (ru) Мутаци в генах oas1
WO2007008486A3 (en) Aav vectors encoding superoxide dismutase
ATE378415T1 (de) In cis regulierte konditionelle genvektoren
WO2006046073A3 (en) C1q related protein
WO2007061690A3 (en) Novel pharmaceutical compositions for the treatment of virus infection and cancer
TW200724679A (en) Treatment of disease using an improved regulated expression system
DE60233756D1 (de) Vektorvermittelte organellentransfektion
TW200621718A (en) Novel co-crystals
GB0324656D0 (en) A protein involved in ovarian cancer
DE60036548D1 (de) Neue kalium-kanäle und dafür kodierende gene
TW200716749A (en) Interferon-beta gene therapy using an improved, regulated expression system
WO2008014470A3 (en) Adult sertoli cells and uses thereof
GB0616061D0 (en) Peptides and uses thereof
GB0423126D0 (en) Protein
Eom et al. Chemo-enzymatic Synthesis of Lysophospholipd, Monoacylglycerol sulfate and their Biological Effect
TW200617021A (en) Isolated photoprotein aequorin y89f, and its use
Tetsuo Recent Topics of Genetic Polymorphism in Drug Therapy
WO2006000753A3 (en) Use of flj40787, a protein involved in colon, colorectal, ovarian, lung and/or liver cancer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1634955

Country of ref document: EP